Pressing on the chest wall often brings out the pain
Ozempic is FDA-approved for improving glycemic control in adults with type 2 diabetes and reducing the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease
In addition, GLP-1RAs block oxidized LDL (ox-LDL)-induced monocyte adhesion to endothelial cells via regulating the ERK5/KLF2 signaling pathway (Yue et al., 2019)
Researchers at the National Institute on Drug Abuse (NIDA) are currently conducting a clinical trial to learn more about this connection, including semaglutides potential impacts on other addictive behaviors, like smoking and substance use
Starting in January 2025, Ozempic gained FDA approval for reducing kidney disease risks in adults with type 2 diabetes who also have chronic kidney disease
Patients who learn their genetic GLP-1 sensitivity through this test often find they achieve their goals faster, reduce side effects, and avoid wasting time or money on suboptimal formulations
.webp)
